1,9-dideoxyforskolin has been researched along with rubidium in 2 studies
| Studies (1,9-dideoxyforskolin) | Trials (1,9-dideoxyforskolin) | Recent Studies (post-2010) (1,9-dideoxyforskolin) | Studies (rubidium) | Trials (rubidium) | Recent Studies (post-2010) (rubidium) |
|---|---|---|---|---|---|
| 111 | 0 | 2 | 5,163 | 18 | 269 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronstam, RS; Daly, JW; Nishizawa, Y; Seamon, KB | 1 |
| McGee, R; McHugh, EM | 1 |
2 other study(ies) available for 1,9-dideoxyforskolin and rubidium
| Article | Year |
|---|---|
Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells.
Topics: Adrenal Gland Neoplasms; Animals; Calcium; Carbachol; Colforsin; Ion Channel Gating; Ion Channels; Neurotoxins; Pheochromocytoma; Potassium; Rats; Receptors, Nicotinic; Rubidium; Sodium; Tumor Cells, Cultured | 1990 |
Direct anesthetic-like effects of forskolin on the nicotinic acetylcholine receptors of PC12 cells.
Topics: Adenylyl Cyclases; Adrenal Gland Neoplasms; Anesthetics; Animals; Carbachol; Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Pheochromocytoma; Rats; Receptors, Cholinergic; Rubidium; Time Factors | 1986 |